Journals | Policy | Permission

Gastroenterology Research

Case Report

Volume 10, Number 6, December 2017, pages 366-368

Primary Jejunal Adenocarcinoma Presenting as Bilateral Ovarian Metastasis

Small intestinal tumors are uncommon worldwide. Specifically, adenocarcinoma of the small intestines is a very rare clinical entity. It accounts for 1-2% of all gastrointestinal malignancies and about 25-40% of malignant carcinomas of the small intestines [1]. A large proportion of small intestine malignancy is duodenal adenocarcinoma with primary jejunal adenocarcinoma rarely encountered [2]. Small intestine adenocarcinoma is challenging to diagnose preoperatively mainly due to its non-specific clinical presentation and difficult endoscopic access to the duodenum and jejunum. Additionally, patients present with vague symptoms of abdominal pain, nausea, vomiting, anemia, bleeding and signs of obstruction [3]. As a result, the diagnosis of small intestinal malignancy is usually delayed, missed, or only detected at advanced stages [2]. Herein, we describe a rare case of a 37-year-old woman with suspected bilateral ovarian malignancy, which proved to be a primary jejunal adenocarcinoma with ovarian metastasis. We discuss the salient clinical and pathophysiologic features of this malignancy.

A 37-year-old female with a past medical history of bilateral ovarian tumors status post total abdominal hysterectomy with bilateral salpingo-oophorectomy 1 month prior, presented with abdominal pain. Her abdominal pain was dull, located in the right lower quadrant and epigastric regions of the abdomen, and associated with nausea and non-bloody bilious vomiting. She had regular bowel movements and passed flatus. The patient denied fever, chills, hematochezia or melena. Physical examination noted a soft, non-tender and non-distended abdomen. Laboratory findings showed white cell count of 6,700/mm³, hemoglobin of 11.5 g/dL, and normal lactic acid and lipase levels.

Abdominal computed tomography (CT) scan showed mildly dilated loops of small intestine in the left upper quadrant, measuring 3.6 cm in diameter, with a distal mass-like transition (Fig. 1). Push enteroscopy with a pediatric colonoscope revealed an almost obstructing jejunal mass about 60 cm distally to the duodenal bulb (Fig. 2). Colonoscopy was unremarkable. Biopsy of the jejunal mass showed an invasive moderately differentiated adenocarcinoma of the small intestine (Fig. 3). The patient underwent laparoscopic small bowel resection with primary anastomosis and omental biopsy. Final pathology report revealed a moderately differentiated, infiltrating adenocarcinoma, invading the perijejunal adipose tissue with lymph node involvement.

Click for large image

Figure 1. CT scan of abdomen shows dilated loop of small intestine in the left upper quadrant.

Click for large image

Figure 2. Near obstructing jejunal mass about 60 cm distally to the duodenal bulb.

Click for large image

Figure 3. Micrographic examination reveals benign jejunal glands (arrow) and metastatic adenocarcinoma (asterisks) in the lamina propria (a: × 40; b: × 100).

Immunohistochemical staining revealed that the adenocarcinoma was positive for CDX-2 and CK7, and negative for chromogranin, CK20, and synaptophysin. Histopathological examination of the resected ovarian specimen was CDX-2 positive, cytokeratin 7 positive, cytokeratin 20 negative, cytokeratin 5/6 negative, CA-125 negative, mammoglobin negative, estrogen receptor negative, WT-1 negative, napsin negative, and TTF-1 negative. These cytomorphology and immunophenotypical findings strongly supported the diagnosis of primary gastrointestinal adenocarcinoma.

Small intestinal tumors are uncommon, making up about 2.3% of all gastrointestinal malignancies in the United States [4]. Of these small intestinal malignancies, adenocarcinoma accounts for about 30-40% with the highest incidence found within the duodenum [2, 4]. The mean age at diagnosis is generally in the fifth decade of life with a male predominance [5, 6]. The clinical presentation of small bowel adenocarcinoma is non-specific and includes abdominal pain (50-75%), nausea/vomiting (33-72.5%), weight loss (38-52.5%), intestinal obstruction (31.3-44%), and gastrointestinal bleeding (23-33%) [6]. Similarly, primary jejunal adenocarcinoma presents with vague symptoms of abdominal pain, nausea and vomiting, anemia, bleeding, weight loss and signs of obstruction [7].

Small intestine adenocarcinoma is rare due to a culmination of various hypothesized explanations such as low bacterial content of the small intestines, presence of enzyme benzopyrene hydroxylase, rapid turnover of epithelial cells, protective lymphoid tissue, and the presence of bile acids [8, 9]. The fast passage of food through the small intestine provides low mucosal contact time, thereby reducing mucosal injury [4]. Gill et al also hypothesized that the increased levels of IgA expression in the small intestine may serve as mucosal protection against malignancy [10].

In addition to the rarity of jejunal adenocarcinomas, they are usually difficult to diagnose preoperatively. The location of jejunal adenocarcinoma in the small intestine poses difficulty with endoscopic access. As a result, the diagnosis of jejunal adenocarcinoma and other small intestine malignancies is usually delayed, missed, or only detected at advanced stages with poor prognosis [11]. Diagnostic modalities available for detecting small bowel tumors are many; however, they lack an established consensus on the sequence or extent of diagnostic workup. Available for preoperative diagnoses are CT scans, small bowel series, enteroclysis, upper endoscopy, wireless video capsule endoscopy, push enteroscopy and double-balloon endoscopy [11-14]. Laparoscopy followed by frozen section biopsy provides a more definitive diagnosis. However, in the past decade, balloon-assisted enteroscopy (BAE) and capsule endoscopy have gained popularity as useful modalities for diagnosing small bowel diseases.

Cancer-directed surgery provides the best 5-year survival for patients with small intestine cancers. Most studies report a 5-year survival of 15-35% with improvement to 40-65% after surgery [15]. Studies have not shown chemotherapy to provide any significant survival benefit [16].

Jejunal adenocarcinoma is rare with very dire prognosis. While the clinical outcome of jejunal adenocarcinoma remains grim, it is important to remember that early cancer detection coupled with cancer-directed surgery provides a favorable survival benefit. Physicians should therefore have a high index of suspicion for jejunal adenocarcinoma in patients with vague symptoms of abdominal pain, nausea, vomiting, gastrointestinal bleeding, weight loss, and signs of obstruction. Our case demonstrates the unusual presentation of primary jejunal adenocarcinoma presenting as bilateral ovarian malignancy.

Conflict of Interest

The authors declare that they have no conflict of interest.

Human/Animal Rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 [5].

Consent

Informed consent was obtained from all patients to be included in the study.

1. Weiss NS, Yang CP. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst. 1987;78(4):653-656.
   pubmed
2. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518-526.
   doi pubmed
3. Lee HJ, Cha JM, Lee JI, Joo KR, Jung SW, Shin HP. A case of jejunal adenocarcinoma diagnosed by preoperative double balloon enteroscopy. Gut Liver. 2009;3(4):311-314.
   doi pubmed
4. Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011;3(3):33-42.
   doi pubmed
5. Naef M, Buhlmann M, Baer HU. Small bowel tumors: diagnosis, therapy and prognostic factors. Langenbecks Arch Surg. 1999;384(2):176-180.
   doi pubmed
6. Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002;137(5):564-570; discussion 570-561.
7. Iusco DR, Altilia F, Massa ST, Schirone S, Villani P, Roggia G. Jejunal adenocarcinoma: still an elusive diagnosis. Case report and review of the literature. Chir Ital. 2008;60(3):457-462.
   pubmed
8. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007;14(8):2263-2269.
   doi pubmed
9. Pilleul F, Penigaud M, Milot L, Saurin JC, Chayvialle JA, Valette PJ. Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology. 2006;241(3):796-801.
   doi pubmed
10. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum. 2002;45(11):1496-1502.
    doi pubmed
11. Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy. 2005;37(10):960-965.
    doi pubmed
12. Buckley JA, Siegelman SS, Jones B, Fishman EK. The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr. 1997;21(6):986-991.
    doi pubmed
13. Laurent F, Raynaud M, Biset JM, Boisserie-Lacroix M, Grelet P, Drouillard J. Diagnosis and categorization of small bowel neoplasms: role of computed tomography. Gastrointest Radiol. 1991;16(2):115-119.
    doi pubmed
14. de Leusse A, Vahedi K, Edery J, Tiah D, Fery-Lemonnier E, Cellier C, Bouhnik Y, et al. Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding? Gastroenterology. 2007;132(3):855-862; quiz 1164-1165.
    doi pubmed
15. Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol. 2001;33(4):267-282.
    doi pubmed
16. Young JI, Mongoue-Tchokote S, Wieghard N, Mori M, Vaccaro GM, Sheppard BC, Tsikitis VL. Treatment and survival of small-bowel adenocarcinoma in the United States: a comparison with colon cancer. Dis Colon Rectum. 2016;59(4):306-315.
    doi pubmed

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gastroenterology Research is published by Elmer Press Inc.